MedTrace Logo

the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .

NCT02655146 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2016-01-13

No results posted yet for this study

Summary

The aim of the present prospective randomized controlled study was to determine the effects of GnRHa add up to routine luteal phase support on frozen embryo implantation in frozen embryo transfer (FET).

Conditions

Interventions

DRUG

triptorelin 0.1

a single dose of decapeptyl 0.1 s.c. on the 3rd day of embryo transfer with routine luteal phase support.

DRUG

E2

Patients will be on the Progynova tablets 4-10mg daily at least 14 days.

DRUG

Progesterone

After ultrasound and hormorne tests, progesterone 100mg intramuscular injection is allocated with Progynova.

DRUG

triptorelin 3.75mg

as a pretreatment of E2 in some subjects with a fail history of hormonal artificially endometrium preparing.

Sponsors & Collaborators

  • Chong Qing Reproducive and Genetic Institute

    lead OTHER

Principal Investigators

  • Hong Ye, bachelor · chong qing reproductive and genetic institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-31
Completion
2017-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02655146 on ClinicalTrials.gov